Published in Eur Urol on January 26, 2010
Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol (2012) 3.35
Diffusion of surgical innovations, patient safety, and minimally invasive radical prostatectomy. JAMA Surg (2014) 2.79
Comparison of open and robotic-assisted prostatectomy: The University of British Columbia experience. Can Urol Assoc J (2014) 1.54
Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis. Yonsei Med J (2016) 1.42
Benchmarks for operative outcomes of robotic and open radical prostatectomy: results from the Health Professionals Follow-up Study. Eur Urol (2014) 1.21
Using a population-based observational cohort study to address difficult comparative effectiveness research questions: the CEASAR study. J Comp Eff Res (2013) 0.99
Direct-to-consumer Internet promotion of robotic prostatectomy exhibits varying quality of information. Health Aff (Millwood) (2012) 0.97
Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health. World J Urol (2012) 0.95
Evidence-based comparison of robotic and open radical prostatectomy. ScientificWorldJournal (2010) 0.91
Outcomes assessment in men undergoing open retropubic radical prostatectomy, laparoscopic radical prostatectomy, and robotic-assisted radical prostatectomy. World J Urol (2011) 0.84
Low quality of evidence for robot-assisted laparoscopic prostatectomy: a problem not only in the robotic literature. Eur Urol (2010) 0.81
Efficacy of robotic-assisted prostatectomy in localized prostate cancer: a systematic review of clinical trials. Adv Urol (2013) 0.78
On ne peut se permettre d'accuser du retard. Can Urol Assoc J (2012) 0.75
Radical retropubic prostatectomy: comparison of the open and robotic approaches for treatment of prostate cancer. Rev Urol (2012) 0.75
Poor quality of published evidence for superiority of RAlP. Nat Rev Urol (2010) 0.75
We can't afford to be laggards. Can Urol Assoc J (2012) 0.75
Laparoscopy/new technology. J Urol (2010) 0.75
Low quality of evidence for robot-assisted laparoscopic prostatectomy: what about the evidence for open? Eur Urol (2010) 0.75
The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy. World J Urol (2013) 0.75
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol (2010) 11.77
Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. BMJ (2010) 7.15
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells. J Clin Invest (2005) 5.30
GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol (2013) 3.58
GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol (2011) 3.30
GRADE guidelines: 7. Rating the quality of evidence--inconsistency. J Clin Epidemiol (2011) 3.02
Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. J Urol (2013) 2.76
Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ (2012) 2.69
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 2.42
Castration-resistant prostate cancer: AUA Guideline. J Urol (2013) 2.36
Screening for prostate cancer. Cochrane Database Syst Rev (2013) 2.29
A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. J Urol (2007) 2.16
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest (2002) 2.09
GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol (2012) 1.90
Telomerase mRNA-transfected dendritic cells stimulate antigen-specific CD8+ and CD4+ T cell responses in patients with metastatic prostate cancer. J Immunol (2005) 1.82
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70
Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer. Eur Urol (2012) 1.60
Evaluating the evidence: statistical methods in randomized controlled trials in the urological literature. J Urol (2008) 1.48
Evidence-based urology in practice: publication bias. BJU Int (2010) 1.44
Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association. J Urol (2007) 1.40
How to perform a literature search. J Urol (2008) 1.37
Circulating and tumor-infiltrating myeloid cell subsets in patients with bladder cancer. Int J Cancer (2011) 1.27
Reporting of harm in randomized controlled trials published in the urological literature. J Urol (2010) 1.25
How to use a systematic literature review and meta-analysis. J Urol (2008) 1.23
The influence of study characteristics on reporting of subgroup analyses in randomised controlled trials: systematic review. BMJ (2011) 1.17
Reversal of tumor-mediated immunosuppression. Clin Cancer Res (2007) 1.13
Evidence based clinical practice: a primer for urologists. J Urol (2007) 1.13
Predictors of citations in the urological literature. BJU Int (2011) 1.05
Assessing and presenting summaries of evidence in Cochrane Reviews. Syst Rev (2013) 1.05
History of evidence-based medicine. Indian J Urol (2011) 1.04
Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol (2002) 1.02
Evidence-based medicine: a survey of American Urological Association members. J Urol (2006) 1.00
Perceptions and competence in evidence-based medicine: a survey of the American Urological Association Membership. J Urol (2008) 0.99
Enhanced induction of telomerase-specific CD4(+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res (2002) 0.98
Assessment of the methodological quality of systematic reviews published in the urological literature from 1998 to 2008. J Urol (2010) 0.97
Relationship between body mass index and prostate cancer screening in the United States. J Urol (2007) 0.96
Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings. J Urol (2009) 0.96
Evaluating the evidence: the methodological and reporting quality of comparative observational studies of surgical interventions in urological publications. BJU Int (2008) 0.95
Robot-assisted excision of seminal vesicle cyst associated with ipsilateral renal agenesis. J Endourol (2007) 0.94
Clinical research and statistical methods in the urology literature. J Urol (2005) 0.93
Impact of nerve sparing technique on patient self-assessed outcomes after radical perineal prostatectomy. J Urol (2007) 0.92
How to use an article about therapy. J Urol (2008) 0.92
Routine postoperative imaging is important after ureteroscopic stone manipulation. J Urol (2002) 0.91
A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy. J Clin Anesth (2009) 0.91
Barriers to the practice of evidence-based urology. J Urol (2008) 0.91
How to critically appraise a clinical practice guideline. Indian J Urol (2011) 0.90
Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer. Cochrane Database Syst Rev (2014) 0.89
Evidence-based urology in practice: how to use PubMed effectively. BJU Int (2009) 0.88
Tumour-seeding: a rare complication of ablative therapy for clinically localised renal cell carcinoma. BMJ Case Rep (2012) 0.88
Evidence-based medicine in urology. World J Urol (2011) 0.88
Levels of evidence in the urological literature. J Urol (2007) 0.88
Prediction of lower pole stone clearance after shock wave lithotripsy using an artificial neural network. J Urol (2003) 0.87
The future of clinical practice guidelines in urology. Eur Urol (2011) 0.87
Evidence-based medicine training in residency: a survey of urology programme directors. BJU Int (2009) 0.86
Reporting quality and information consistency of randomized, controlled trials presented as abstracts at the American Urological Association annual meetings. J Urol (2010) 0.85
Urological cancer care pathways: development and use in the context of systematic reviews and clinical practice guidelines. World J Urol (2011) 0.85
Selective adherence to antihypertensive medications as a patient-driven means to preserving sexual potency. Patient Prefer Adherence (2008) 0.85
Prospective health-related quality-of-life assessment in an initial cohort of patients undergoing robotic radical prostatectomy. Urology (2006) 0.85
The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy. J Urol (2007) 0.84
Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis. J Clin Epidemiol (2013) 0.84
How to use an article about a diagnostic test. J Urol (2008) 0.84
Levels of evidence ratings in the urological literature: an assessment of interobserver agreement. BJU Int (2010) 0.83
Study characteristics of abstracts presented at the annual meetings of the southeastern section of the American Urological Association (1996-2005). J Urol (2007) 0.83
Rating the quality of evidence and the strength of recommendations using GRADE. World J Urol (2011) 0.83
Transurethral electrovaporization vs transurethral resection for symptomatic prostatic obstruction: a meta-analysis. BJU Int (2004) 0.82
Prospective and longitudinal patient self-assessment of health-related quality of life following radical perineal prostatectomy. J Urol (2004) 0.82
Evaluation and management of blunt traumatic aortic injury: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg (2015) 0.82
Prostate-cancer mortality after PSA screening. N Engl J Med (2012) 0.81
Radical perineal prostatectomy for treatment of localized prostate cancer in obese and nonobese patients: a matched control study. Urology (2006) 0.81
Evidence-based urology in practice: composite endpoints. BJU Int (2010) 0.81
Understanding results. J Urol (2009) 0.81
Evidence-based urology in practice: likelihood ratios. BJU Int (2009) 0.80
Psychosocial interventions for men with prostate cancer. Cochrane Database Syst Rev (2013) 0.80
The Eastern Association of the Surgery of Trauma approach to practice management guideline development using Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) methodology. J Trauma Acute Care Surg (2012) 0.79
Evidence-based urology in practice: when to believe a subgroup analysis? BJU Int (2009) 0.79
Cross-sectional survey of long-term quality of life after radical perineal prostatectomy. Urology (2005) 0.79
Screening for prostate cancer: shaping the debate on benefits and harms. Cochrane Database Syst Rev (2013) 0.79
Evaluation and management of blunt traumatic aortic injury: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Nurs (2015) 0.78
Direct-to-consumer advertising for urological pharmaceuticals: a cross-sectional analysis of print media. Urology (2010) 0.78
What every urologist should know about surgical trials Part I: Are the results valid? Indian J Urol (2008) 0.78
PSA screening for prostate cancer. BMJ (2014) 0.78
Evidence-based urology in practice: number needed to treat. BJU Int (2009) 0.78
Interpreting statistics in the urological literature. J Urol (2006) 0.78